Process View
Any process that modulates the frequency, rate or extent of smooth muscle cell migration.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of smooth muscle cell migration"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 1.000 | ||
| VEGFA | vascular endothelial growth factor A | 1.000 | Human | |
| C1QA | complement component 1, q subcomponent, A chain | 0.998 | Human | |
| EGFR | epidermal growth factor receptor | 0.997 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.973 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.973 | ||
| NRP1 | neuropilin 1 | 0.952 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.942 | Human | |
| CCR5 | chemokine (C-C motif) receptor 5 | 0.935 | ||
| FN1 | fibronectin 1 | 0.892 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.799 | ||
| PLAU | plasminogen activator, urokinase | 0.760 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.755 | Human | |
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.747 | ||
| PLAT | plasminogen activator, tissue | 0.720 | Human | |
| IGF2R | insulin-like growth factor 2 receptor | 0.712 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.674 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.644 | ||
| PXN | paxillin | 0.642 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.637 | Human | |
| FYN | FYN oncogene related to SRC, FGR, YES | 0.616 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.549 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.544 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.537 | ||
| GGA2 | golgi-associated, gamma adaptin ear containing, ARF binding protein 2 | 0.533 | ||
| APBB1 | amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) | 0.520 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.518 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.516 | Human | |
| DCN | decorin | 0.487 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.484 | ||
| C1QC | complement component 1, q subcomponent, C chain | 0.473 | Human | |
| CCL4 | chemokine (C-C motif) ligand 4 | 0.447 | Human | |
| GRB2 | growth factor receptor-bound protein 2 | 0.446 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.444 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.364 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.305 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.303 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.246 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.239 | Human | |
| C1QB | complement component 1, q subcomponent, B chain | 0.224 | Human | |
| PLAUR | plasminogen activator, urokinase receptor | 0.216 | ||
| THBS1 | thrombospondin 1 | 0.211 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.205 | ||
| JDP2 | Jun dimerization protein 2 | 0.170 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.169 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.165 | ||
| RABEP1 | rabaptin, RAB GTPase binding effector protein 1 | 0.161 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.156 | Human | |
| ESRRG | estrogen-related receptor gamma | 0.155 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.149 | ||
| POLA2 | polymerase (DNA directed), alpha 2 (70kD subunit) | 0.139 | ||
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.129 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.129 | ||
| PDGFC | platelet derived growth factor C | 0.128 | ||
| IL8 | interleukin 8 | 0.127 | ||
| PPARG | peroxisome proliferator-activated receptor gamma | 0.119 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.106 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.088 | ||
| OSMR | oncostatin M receptor | 0.088 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.087 | Human | |
| JAK2 | Janus kinase 2 | 0.086 | ||
| AXL | AXL receptor tyrosine kinase | 0.083 | ||
| APOE | apolipoprotein E | 0.083 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.082 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.080 | ||
| C1S | complement component 1, s subcomponent | 0.079 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.078 | Human | |
| STC1 | stanniocalcin 1 | 0.077 | ||
| S100B | S100 calcium binding protein B | 0.074 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.073 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.073 | ||
| IL1B | interleukin 1, beta | 0.071 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.070 | ||
| ITGB1BP3 | integrin beta 1 binding protein 3 | 0.065 | ||
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.064 | ||
| SYNRG | synergin, gamma | 0.064 | ||
| ADAM12 | ADAM metallopeptidase domain 12 | 0.064 | ||
| ENG | endoglin | 0.062 | ||
| BCL2L1 | BCL2-like 1 | 0.060 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.059 | ||
| TF | transferrin | 0.057 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.057 | ||
| PARVA | parvin, alpha | 0.056 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.055 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.054 | ||
| IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.053 | ||
| LDLR | low density lipoprotein receptor | 0.052 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.051 | ||
| LAT | linker for activation of T cells | 0.049 | ||
| IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.048 | Human | |
| ATF5 | activating transcription factor 5 | 0.047 | ||
| STAB1 | stabilin 1 | 0.047 | ||
| NNMT | nicotinamide N-methyltransferase | 0.046 | ||
| MEF2A | myocyte enhancer factor 2A | 0.046 | ||
| ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.045 | ||
| PGF | placental growth factor | 0.044 | Human | |
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.044 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.042 | ||
| LTBP2 | latent transforming growth factor beta binding protein 2 | 0.041 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.041 | Rat | |
| CCR1 | chemokine (C-C motif) receptor 1 | 0.040 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.040 | Human | |
| VEGFC | vascular endothelial growth factor C | 0.040 | Human | |
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.040 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.039 | ||
| INHBA | inhibin, beta A | 0.039 | ||
| PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 0.038 | ||
| NOV | nephroblastoma overexpressed gene | 0.038 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.038 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.038 | ||
| KITLG | KIT ligand | 0.038 | ||
| DDIT3 | DNA-damage-inducible transcript 3 | 0.036 | ||
| TTR | transthyretin | 0.036 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.036 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.035 | ||
| FCN2 | ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) | 0.034 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.033 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.033 | ||
| TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | 0.033 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.033 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.032 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.030 | Human | |
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.030 | ||
| IRS1 | insulin receptor substrate 1 | 0.030 | ||
| MEF2C | myocyte enhancer factor 2C | 0.030 | ||
| CUEDC2 | CUE domain containing 2 | 0.030 | ||
| OCRL | oculocerebrorenal syndrome of Lowe | 0.030 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.029 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.028 | Rat | |
| MARCO | macrophage receptor with collagenous structure | 0.027 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.027 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.026 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.026 | ||
| GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.025 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.025 | Human | |
| DARC | Duffy blood group, chemokine receptor | 0.025 | ||
| RICTOR | RPTOR independent companion of MTOR, complex 2 | 0.025 | ||
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.025 | Rat | |
| COL5A1 | collagen, type V, alpha 1 | 0.024 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.024 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.023 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.022 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.022 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.022 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.021 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.021 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.020 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.019 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.019 | ||
| SLAMF8 | SLAM family member 8 | 0.019 | ||
| COL6A2 | collagen, type VI, alpha 2 | 0.019 | ||
| SELE | selectin E | 0.019 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.018 | ||
| LAMA4 | laminin, alpha 4 | 0.018 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.018 | ||
| THBS2 | thrombospondin 2 | 0.018 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.018 | ||
| FLNA | filamin A, alpha | 0.017 | ||
| NRP2 | neuropilin 2 | 0.017 | ||
| PTRF | polymerase I and transcript release factor | 0.016 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.016 | ||
| PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.015 | ||
| ANGPTL4 | angiopoietin-like 4 | 0.015 | ||
| MMP19 | matrix metallopeptidase 19 | 0.015 | ||
| LRRC32 | leucine rich repeat containing 32 | 0.015 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.015 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.015 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.015 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.015 | Human | |
| TGFB1 | transforming growth factor, beta 1 | 0.014 | ||
| PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 0.014 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.014 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.014 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.014 | ||
| EEA1 | early endosome antigen 1 | 0.014 | ||
| CCL21 | chemokine (C-C motif) ligand 21 | 0.014 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.013 | ||
| CD83 | CD83 molecule | 0.013 | ||
| RUNX1T1 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) | 0.013 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.013 | ||
| CD248 | CD248 molecule, endosialin | 0.013 | ||
| RGS16 | regulator of G-protein signaling 16 | 0.013 | ||
| ZYX | zyxin | 0.013 | ||
| TNC | tenascin C | 0.013 | ||
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.013 | Human | |
| THY1 | Thy-1 cell surface antigen | 0.013 | ||
| ORM1 | orosomucoid 1 | 0.012 | ||
| KNG1 | kininogen 1 | 0.012 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.012 | ||
| FST | follistatin | 0.012 | ||
| COL3A1 | collagen, type III, alpha 1 | 0.012 | ||
| GNLY | granulysin | 0.012 | ||
| EHD1 | EH-domain containing 1 | 0.012 | ||
| SPRR2A | small proline-rich protein 2A | 0.012 | ||
| CD163 | CD163 molecule | 0.012 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.012 | ||
| CXCL14 | chemokine (C-X-C motif) ligand 14 | 0.012 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.012 | ||
| MAP2 | microtubule-associated protein 2 | 0.011 | ||
| DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.011 | ||
| AMBRA1 | autophagy/beclin-1 regulator 1 | 0.011 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.011 | ||
| PTHLH | parathyroid hormone-like hormone | 0.011 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.011 | ||
| IGFBP4 | insulin-like growth factor binding protein 4 | 0.011 | Human | |
| COLEC12 | collectin sub-family member 12 | 0.011 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.011 | ||
| PXDN | peroxidasin homolog (Drosophila) | 0.011 | ||
| SRPX | sushi-repeat containing protein, X-linked | 0.011 | ||
| IL32 | interleukin 32 | 0.011 | ||
| PCDH17 | protocadherin 17 | 0.011 | ||
| IGFBP2 | insulin-like growth factor binding protein 2, 36kDa | 0.010 | Human | |
| COL18A1 | collagen, type XVIII, alpha 1 | 0.010 | ||
| PIK3CB | phosphoinositide-3-kinase, catalytic, beta polypeptide | 0.010 | ||
| POSTN | periostin, osteoblast specific factor | 0.010 | ||
| IL10 | interleukin 10 | 0.010 | ||
| GGA1 | golgi-associated, gamma adaptin ear containing, ARF binding protein 1 | 0.010 | ||
| TLN1 | talin 1 | 0.010 | ||
| FRZB | frizzled-related protein | 0.010 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.010 |